Cite
MLA Citation
Julia C. Chisholm et al.. “BRIM‐P: A phase I, open‐label, multicenter, dose‐escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation‐positive melanoma.” Pediatric blood & cancer, vol. 65, no. 5, 2018, p. n/a. http://access.bl.uk/ark:/81055/vdc_100057892457.0x000016